Although we considered the possibility of individual-patient differences in the CTGF level, there was clearly no correlation between the CTGF level and liver fibrosis stage in patients with NAFLD who underwent sequential biopsy. This evidence concerns the gene CCN2 and metabolic dysfunction-associated steatotic liver disease.